MacroGenics
MGNX
125 hedge funds and large institutions have $760M invested in MacroGenics in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 50 increasing their positions, 36 reducing their positions, and 15 closing their positions.
9,075% more call options, than puts
Call options by funds: $734K | Put options by funds: $8K
47% more capital invested
Capital invested by funds: $518M → $760M (+$242M)
39% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 36
1% less funds holding
Funds holding: 126 → 125 (-1)
7% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.4M |
| 2 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$11.7M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.07M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$4.51M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$11.3M |
| 2 |
DM
Deerfield Management
New York
|
-$9.71M |
| 3 |
Millennium Management
New York
|
-$8.45M |
| 4 |
TM
Tiger Management
New York
|
-$5.91M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$4.61M |
MGNX Hedge Fund Activity: Q2 2016 in Review
125 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2016, worth a combined $760M — up 47% from $518M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of MGNX and 14 opened new positions — a net loss of 1 holder — while 36 trimmed existing stakes and 50 added.
The largest buyer was Fidelity Investments, adding an estimated $32.4M. The largest seller was Numeric Investors, cutting an estimated $11.3M.
- 125 institutional investors held MacroGenics (MGNX) as of Q2 2016, down from 126 in Q1 2016.
- Funds reported $760M of MacroGenics stock for Q2 2016, up 47% quarter-over-quarter.
- 14 funds opened new MacroGenics positions in Q2 2016 and 15 closed out, a net change of -1 holder.
- The largest MacroGenics buyer in Q2 2016 was Fidelity Investments, an estimated $32.4M added.
- The largest MacroGenics seller in Q2 2016 was Numeric Investors, an estimated $11.3M sold.
Based on aggregated 13F filings for Q2 2016.